Brief Communications
Posterior Reversible Encephalopathy Syndrome in Liver Transplant Patients: Clinical Presentation, Risk Factors and Initial Management

https://doi.org/10.1111/j.1600-6143.2012.04048.xGet rights and content
Under a Creative Commons license
open archive

Posterior reversible encephalopathy syndrome (PRES) is an uncommon but well-known complication after transplantation diagnosed by characteristic radiological features. As limited data on this complex syndrome exist we sought to better define the incidence, clinical presentation and risk factors for PRES in liver transplant (LTx) patients. We conducted a retrospective analysis of 1923 adult LTx recipients transplanted between 2000 and 2010. PRES was diagnosed radiologically in 19 patients (1%), with 84% of cases occurring within 3 months post-LTX. We compared this cohort of PRES patients to 316 other LTx recipients also requiring radiographic imaging within 3 months after LTx for neurological symptoms. Seizure was the most common clinical manifestation in the PRES group (88% vs. 16%, p< 0.001) and 31% had an intracranial hemorrhage. Those with hemorrhage on imaging were more likely to be coagulopathic. PRES patients were significantly more likely to have had alcoholic liver disease and infection/sepsis. These factors may be related to a common pathway of vascular dysregulation/damage that appears to characterize this complex syndrome. Intracranial bleeding and seizures may be the end result of these phenomena. The relationship of these associated factors to the hypothesized pathophysiology of PRES is discussed.

Key words:

Complications
drug toxicity
immunosuppression
liver transplantation
seizure

Abbreviations:

ACR
acute cellular rejection
CNI
calcineurin inhibitor
CT
computed tomography
ICP
intracranial pressure
LTx
liver transplant
MELD
model for end-stage liver disease
MRI
magnetic resonance imaging
PRES
posterior reversible encephalopathy syndrome

Cited by (0)